| Metric | FY 2014 | Prior Q | FY 2013 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $489M | — | $371M | — | 31.7% |
| Op. Income | $195M | — | $125M | — | 55.9% |
| Gross Margin | 86.8% | — | 85.0% | — | 1.7pp |
| Net Margin | 26.6% | — | 23.1% | — | 3.5pp |
| EPS (Diluted) | $1.92 | — | $1.70 | — | 12.9% |
| Free Cash Flow | $144M | — | $136M | — | 5.5% |
| Item | Amount |
|---|---|
| REVENUE | $489M |
| Cost of Revenue | $65M |
| GROSS PROFIT | $424M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $133M |
| SG&A Expenses | $133M |
| Other Expenses | $96M |
| Operating Expenses | $229M |
| Cost & Expenses | $294M |
| OPERATING INCOME | $195M |
| Interest Income | $419M |
| Interest Expense | $43M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $195M |
| Income Tax Expense | $65M |
| Net Income from Continuing Ops | $130M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $130M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $130M |
| D&A | $2M |
| EBIT | $195M |
| EBITDA | $196M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $489M |
| Cost of Revenue | $65M |
| GROSS PROFIT | $424M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $133M |
| SG&A Expenses | $133M |
| Other Expenses | $96M |
| Operating Expenses | $229M |
| Cost & Expenses | $294M |
| OPERATING INCOME | $195M |
| Interest Income | $419M |
| Interest Expense | $43M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $195M |
| Income Tax Expense | $65M |
| Net Income from Continuing Ops | $130M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $130M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $130M |
| D&A | $2M |
| EBIT | $195M |
| EBITDA | $196M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $130M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $10M |
| Other Non-Cash Items | $14M |
| Change in Working Capital | -$6M |
| OPERATING CASH FLOW | $153M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $97M |
| Purchases of Investments | -$507M |
| Sales/Maturities of Investments | $589M |
| Other Investing Activities | -$383M |
| NET CASH FROM INVESTING | -$213M |
| Net Debt Issuance | $353M |
| Common Stock Repurchased | -$2.0K |
| Common Dividends Paid | -$82M |
| Other Financing Activities | $126M |
| NET CASH FROM FINANCING | $396M |
| FREE CASH FLOW | $144M |
| Net Change in Cash | $336M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $752M |
| Short-Term Investments | $1.2B |
| Net Receivables | $32M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $2.0B |
| PP&E (Net) | $78M |
| Goodwill | $710M |
| Intangible Assets | $0 |
| Long-Term Investments | $9.2B |
| Tax Assets | $0 |
| Other Non-Current Assets | $403M |
| TOTAL NON-CURRENT ASSETS | $10.4B |
| TOTAL ASSETS | $12.3B |
| Account Payables | $0 |
| Short-Term Debt | $488M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $9.0B |
| TOTAL CURRENT LIABILITIES | $9.6B |
| Long-Term Debt | $1.1B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $2M |
| TOTAL NON-CURRENT LIABILITIES | $1.1B |
| TOTAL LIABILITIES | $10.7B |
| Common Stock | $173M |
| Additional Paid-In Capital | $743M |
| Retained Earnings | $776M |
| Treasury Stock | -$633.0K |
| Accum. Other Comp. Income | -$36M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.7B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.7B |
| TOTAL LIABILITIES & EQUITY | $12.3B |
| Total Debt | $1.5B |
| Net Debt | $789M |